Therapeutics for the treatment of multiple myeloma (MM), schizophrenia and hepatitis C (HCV).
Novel peptides focused on metabolic and inflammatory diseases.
Sunesis is leading the discovery, optimization, and early development of pharmaceuticals for the treatment of major human diseases
Translating RNA-based discoveries into innovative products
a biotechnology company focused on enhancing the survival of cancer patients through monoclonal antibody-based therapeutics
novel RNAi-based therapeutics
Feeding of the genomics in order to discover therapeutic of the novel for the psychiatric disorders
Protein Therapeautics Development
Development of novel therapeutics
Genetically-targeted therapies for cardiovascular diseases